Liu Yichen, Wang Lei, Liu Wen
Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, Fujian, 361102, People's Republic of China.
Cancer Manag Res. 2022 May 31;14:1847-1856. doi: 10.2147/CMAR.S362594. eCollection 2022.
Circular RNAs (circRNAs) are a class of non-coding RNAs with loop structures that are stable and widely distributed in different tumor tissues. The development of high-throughput sequencing and in silico tools has enabled the discovery of numerous functional circRNAs. Hepatocellular carcinoma (HCC) is a malignant tumor, and the mechanism involved in its progression has remained unclear. In recent years, an increasing number of circRNAs have been identified in HCC, contributing to tumorigenesis and metastasis and with the potential role as biomarkers through competitive endogenous RNAs (ceRNAs) as miRNA sponges or by interacting with RNA binding proteins (RBPs). In this review, we summarize the regulatory roles of circRNAs in HCC development as well as the use of bioinformatics tools in the annotation and prioritization of circRNA and highlight the participation of exosomal circRNAs in HCC metastasis and drug resistance.
环状RNA(circRNAs)是一类具有环状结构的非编码RNA,其稳定且广泛分布于不同肿瘤组织中。高通量测序和计算机分析工具的发展使得众多功能性circRNAs得以发现。肝细胞癌(HCC)是一种恶性肿瘤,其进展所涉及的机制仍不清楚。近年来,在HCC中已鉴定出越来越多的circRNAs,它们通过作为微小RNA(miRNA)海绵的竞争性内源性RNA(ceRNAs)或与RNA结合蛋白(RBPs)相互作用,促进肿瘤发生和转移,并具有作为生物标志物的潜在作用。在本综述中,我们总结了circRNAs在HCC发展中的调控作用,以及生物信息学工具在circRNA注释和优先级排序中的应用,并强调了外泌体circRNAs在HCC转移和耐药性中的作用。